| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥13.29B | ¥12.51B | +6.2% |
| Cost of Sales | ¥10.08B | ¥9.38B | +7.4% |
| Gross Profit | ¥3.21B | ¥3.13B | +2.4% |
| SG&A Expenses | ¥1.69B | ¥1.61B | +5.3% |
| Operating Income | ¥1.52B | ¥1.53B | -0.6% |
| Non-operating Income | ¥258M | ¥250M | +3.1% |
| Non-operating Expenses | ¥41M | ¥21M | +97.1% |
| Ordinary Income | ¥1.73B | ¥1.75B | -1.2% |
| Profit Before Tax | ¥1.72B | ¥1.79B | -3.6% |
| Income Tax Expense | ¥469M | ¥543M | -13.6% |
| Net Income | ¥1.25B | ¥1.24B | +0.8% |
| Net Income Attributable to Owners | ¥1.25B | ¥1.24B | +0.8% |
| Total Comprehensive Income | ¥2.69B | ¥978M | +174.7% |
| Depreciation & Amortization | ¥516M | ¥500M | +3.3% |
| Interest Expense | ¥1M | ¥3M | -70.2% |
| Basic EPS | ¥64.43 | ¥63.94 | +0.8% |
| Dividend Per Share | ¥30.00 | ¥30.00 | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥33.52B | ¥28.50B | +¥5.01B |
| Cash and Deposits | ¥20.26B | ¥15.42B | +¥4.84B |
| Accounts Receivable | ¥6.98B | ¥6.95B | +¥32M |
| Inventories | ¥1.74B | ¥2.06B | ¥-321M |
| Non-current Assets | ¥23.04B | ¥25.80B | ¥-2.76B |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥1.57B | ¥1.83B | ¥-256M |
| Investing Cash Flow | ¥4.43B | ¥-5.47B | +¥9.89B |
| Financing Cash Flow | ¥-1.07B | ¥-538M | ¥-531M |
| Free Cash Flow | ¥6.00B | - | - |
| Item | Value |
|---|---|
| Net Profit Margin | 9.4% |
| Gross Profit Margin | 24.1% |
| Current Ratio | 629.2% |
| Quick Ratio | 596.6% |
| Debt-to-Equity Ratio | 0.17x |
| Interest Coverage Ratio | 1510.96x |
| EBITDA Margin | 15.3% |
| Effective Tax Rate | 27.2% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +6.2% |
| Operating Income YoY Change | -0.6% |
| Ordinary Income YoY Change | -1.2% |
| Net Income Attributable to Owners YoY Change | +0.8% |
| Total Comprehensive Income YoY Change | +174.6% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 20.28M shares |
| Treasury Stock | 819K shares |
| Average Shares Outstanding | 19.46M shares |
| Book Value Per Share | ¥2,480.75 |
| EBITDA | ¥2.03B |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥30.00 |
| Year-End Dividend | ¥45.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| ConstructionMaterial | ¥1.87B | ¥275M |
| Medicine | ¥11.42B | ¥1.75B |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥26.20B |
| Operating Income Forecast | ¥2.68B |
| Ordinary Income Forecast | ¥3.10B |
| Net Income Attributable to Owners Forecast | ¥2.22B |
| Basic EPS Forecast | ¥114.08 |
| Dividend Per Share Forecast | ¥45.00 |
| Property, Plant & Equipment | ¥8.37B | ¥8.42B | ¥-55M |
| Intangible Assets | ¥104M | ¥112M | ¥-8M |
| Investment Securities | ¥11.16B | ¥8.85B | +¥2.31B |
| Total Assets | ¥56.56B | ¥54.30B | +¥2.26B |
| Current Liabilities | ¥5.33B | ¥5.66B | ¥-337M |
| Accounts Payable | ¥2.73B | ¥2.74B | ¥-12M |
| Short-term Loans | ¥80M | ¥264M | ¥-184M |
| Non-current Liabilities | ¥2.96B | ¥2.16B | +¥795M |
| Total Liabilities | ¥8.28B | ¥7.83B | +¥458M |
| Total Equity | ¥48.28B | ¥46.48B | +¥1.80B |
| Capital Stock | ¥1.03B | ¥1.03B | ¥0 |
| Capital Surplus | ¥857M | ¥857M | ¥0 |
| Retained Earnings | ¥41.27B | ¥40.91B | +¥365M |
| Treasury Stock | ¥-921M | ¥-921M | +¥73,000 |
| Owners' Equity | ¥48.28B | ¥46.48B | +¥1.80B |
| Working Capital | ¥28.19B | - | - |